90 related articles for article (PubMed ID: 29075126)
1. Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45.
Zhou P; Lugovskoy AA; McCarty JS; Li P; Wagner G
Proc Natl Acad Sci U S A; 2001 May; 98(11):6051-5. PubMed ID: 11371636
[TBL] [Abstract][Full Text] [Related]
2. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract][Full Text] [Related]
3. Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.
Bateman NW; Abulez T; Tarney CM; Bariani MV; Driscoll JA; Soltis AR; Zhou M; Hood BL; Litzi T; Conrads KA; Jackson A; Oliver J; Ganakammal SR; Schneider F; Dalgard CL; Wilkerson MD; Smith B; Borda V; O'Connor T; Segars J; Shobeiri SA; Phippen NT; Darcy KM; Al-Hendy A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38723985
[TBL] [Abstract][Full Text] [Related]
4. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray crystallographic studies of the CIDE-domain complex between Drep2 and Drep3 from Drosophila melanogaster.
Park OK; Park HH
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Apr; 67(Pt 4):457-60. PubMed ID: 21505240
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma.
Yasutake N; Ohishi Y; Taguchi K; Hiraki Y; Oya M; Oshiro Y; Mine M; Iwasaki T; Yamamoto H; Kohashi K; Sonoda K; Kato K; Oda Y
Histopathology; 2018 Apr; 72(5):739-748. PubMed ID: 29077232
[TBL] [Abstract][Full Text] [Related]
7. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
Guo J; Zheng J; Tong J
Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
[TBL] [Abstract][Full Text] [Related]
8. Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Amor AR; Fard SS; Tamm EP; Jiang Q; Lundin V; Nilsson A; Holm F
EJHaem; 2023 Feb; 4(1):115-124. PubMed ID: 36819185
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature.
de Almeida BC; Dos Anjos LG; Dobroff AS; Baracat EC; Yang Q; Al-Hendy A; Carvalho KC
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289829
[TBL] [Abstract][Full Text] [Related]
10. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
Sparić R; Andjić M; Babović I; Nejković L; Mitrović M; Štulić J; Pupovac M; Tinelli A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077127
[TBL] [Abstract][Full Text] [Related]
11. Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.
Kulbay M; Johnson B; Ricaud G; Séguin-Grignon MN; Bernier J
Mol Cell Biochem; 2022 Sep; 477(9):2213-2233. PubMed ID: 35460011
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.
Travaglino A; Raffone A; Raimondo D; Gencarelli A; Esposito I; Gallo C; Improda FP; Vitale SG; Mollo A; Casadio P; Seracchioli R; Zullo F; Insabato L
Arch Gynecol Obstet; 2023 Feb; 307(2):379-386. PubMed ID: 35344084
[TBL] [Abstract][Full Text] [Related]
13. Fourier Transform Infrared Spectroscopy: An Innovative Method for the Diagnosis of Ovarian Cancer.
Li L; Wu J; Yang L; Wang H; Xu Y; Shen K
Cancer Manag Res; 2021; 13():2389-2399. PubMed ID: 33737836
[TBL] [Abstract][Full Text] [Related]
14. The role of the DFF40/CAD endonuclease in genomic stability.
Kulbay M; Bernier-Parker N; Bernier J
Apoptosis; 2021 Feb; 26(1-2):9-23. PubMed ID: 33387146
[TBL] [Abstract][Full Text] [Related]
15. Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein.
Barazesh M; Mostafavipour Z; Kavousipour S; Mohammadi S; Mokarram P
Adv Pharm Bull; 2019 Aug; 9(3):423-431. PubMed ID: 31592077
[No Abstract] [Full Text] [Related]
16. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.
Rubisz P; Ciebiera M; Hirnle L; Zgliczyńska M; Łoziński T; Dzięgiel P; Kobierzycki C
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845657
[TBL] [Abstract][Full Text] [Related]
17. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
18. DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.
Banas T; Pitynski K; Okon K; Czerw A
Onco Targets Ther; 2017; 10():4579-4589. PubMed ID: 29075126
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
